Advertisement
Advertisement
Study decoded · health · Confirmed
IV Iron Outperforms Oral Iron For Pregnancy Anemia In 29-Trial Meta-Analysis
29 RCTs, 11,771 Women37% Fewer Transfusions43% Fewer Side EffectsHigher Hemoglobin & Ferritin
A meta-analysis of 29 randomized trials covering 11,771 pregnant women, published in JAMA Network Open on September 23, 2026, found that intravenous iron outperformed oral iron for treating iron deficiency anemia. Women who received IV iron had hemoglobin levels 0.59 g/dL higher and a 37% lower rate of blood transfusion during delivery.
Researchers updated a 2018 systematic review, searching five databases from February 17, 2018, through May 6, 2025, and combined 10 new trials with those from the earlier review after one was retracted, for a total of 29 randomized trials and 11,771 participants. Compared with oral iron, IV iron was linked to maternal hemoglobin 0.59 g/dL higher (15 studies) and maternal ferritin 50.93 ng/mL higher (8 studies) at delivery, plus neonatal ferritin 21.38 ng/mL higher (8 studies). Blood transfusion rates were 37% lower with IV iron (14 studies), and 42% lower among women whose pretreatment hemoglobin was 9 g/dL or less (6 studies). Mild adverse effects were 43% lower with IV iron across 31 studies, and no serious adverse events were reported in either group.
IV Iron Lowers Blood Transfusion Risk 37% and Mild Side Effects 43% vs Oral Iron
Oral iron pills depend on absorption through the gut lining, which is limited and often triggers nausea, constipation or cramping that leads many pregnant women to skip doses. IV iron delivers iron directly into the bloodstream, bypassing that gut bottleneck, which the researchers say may explain why it built ferritin stores and raised hemoglobin faster than pills. Higher ferritin, a marker of stored iron, also carried over to newborns, suggesting better iron reserves at birth.
Funding and conflicts of interest were not reported in the available record. The trials pooled different IV iron formulations and dosing schedules under one comparison, and hemoglobin and ferritin are surrogate lab markers rather than direct measures of outcomes like preterm birth or infant development.
Data Panel
- Who
- 29 randomized trials, 11,771 pregnant women with iron deficiency anemia; search updated through May 6, 2025
- Design
- Updated systematic review and meta-analysis of randomized controlled trials comparing IV iron vs oral iron for treating iron deficiency anemia in pregnancy
- Dose
- Various IV and oral iron formulations and dosing schedules across the 29 included trials; not standardized
- Primary result
- Maternal hemoglobin 0.59 g/dL higher (95% CI 0.31-0.87, 15 studies) and maternal ferritin 50.93 ng/mL higher (95% CI 33.56-68.29, 8 studies) with IV iron vs oral iron at delivery
- Secondary
- Neonatal ferritin 21.38 ng/mL higher (95% CI 5.50-37.25, 8 studies); blood transfusion 37% lower (RR 0.63, 95% CI 0.49-0.82, 14 studies), 42% lower among women with hemoglobin 9 g/dL or less (RR 0.58, 95% CI 0.45-0.76, 6 studies); mild adverse effects 43% lower (RR 0.56, 95% CI 0.41-0.76, 31 studies); no serious adverse events reported
- Funding / conflicts
- Not reported
Dr. Axe's Take
If I had a pregnant patient with anemia that wasn't responding to iron-rich foods or standard oral supplements, this data would push me to ask her OB about IV iron sooner rather than cycling through more pills that upset her stomach. A 37% drop in transfusions and 43% fewer side effects with IV iron are worth a direct conversation with her doctor, especially if her hemoglobin sits at or below 9 g/dL. I still want every pregnant woman eating iron-rich foods like grass-fed beef liver, lentils and pumpkin seeds alongside vitamin C to support absorption. Keep taking iron exactly as your doctor prescribes, and bring this study to your next prenatal visit.
— Dr. AxeDr. Axe Quiz